Font Size: a A A
Keyword [Systemic sclerosis]
Result: 81 - 100 | Page: 5 of 9
81. Study On Anti-endothelin Receptor Type A Autoantibodies In The Serum Of Patients With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
82. The Signification Of Bulbar Conjunctiva Microcirculation On PAH Associated SSc In Rabbits And VEGF’s Correlation Research
83. Study On The Vascular Mechanism Of Treating The Scleroderma By Dangguisini Decoction On AECA,vWF,TXB2,6-keto-PGF1α From Scleroderma Model Mice
84. The Role Of Macrophage Migration Inhibitory Factor In Rabbit Model Of Systemic Sclerosis Associated Pulmonary Arterial Hypertension
85. Diagnostic Value Of CXCL-4 Detection In Patients With Systemic Sclerosis Complicated With Interstitial Lung Disease
86. The Clinical Significance Of HLA-DR15 Expression In Abnormal Thyroid Hormone Levels In Patients With SSc
87. Pirfenidone Attenuates Lung Fibrosis By Interfering With The Hedgehog Pathway
88. The Efficacy And Mechanism Of Allogenic Mesenchymal Stem Cell Transplantation For Autoimmune Diseases
89. The Clinical Cohort Study Of Systemic Sclerosis And Biomarker Validate Study Of Systemic Sclerosis Associated Interstitial Lung Disease
90. The Role And Mechanism Of IL-33/ST2 In Skin Fibrosis Of Systemic Sclerosis
91. Absolute Reduction Of Peripheral CD4~+regulatory T Cell Subset Of Patients With Systemic Sclerosis And Its Restoration By Short-term And Low Dose IL-2 Treatment
92. Regulatory Effect Of Metformin On Bleomycin Induced Systemic Sclerosis Mice
93. Clinical Analysis Of Heart Damage In Connective Tissue Disease
94. Effect Of Maimendong Decoction On Model Animals Of Systemic Sclerosis:Observation Of The Levels Of VEGF、PDGF、ET-1、ANG-Ⅱ In Serum
95. Investigation Of The Role Of Innate Immunity In Pathogenesis Of Autoimmunity-associated Pulmonary Fibrosis
96. Clinical Analysis Of Systemic Sclerosis Complicated With Interstitial Lung Disease
97. The Serum Levels Of Biomarkers (CXCL5,E-Selectin,VEGF,IL-33,IL-35)about Vascular Injury And Clinical Significance During The Course Of Systemic Sclerosis
98. Clinical Characteristics And Survival Of Connective Tissue Diseases With Pulmonaryarterial Hypertension
99. Clinical Characteristics And Treatment Effects Of Systemic Sclerosis Complicated With Pulmonary Interstitial Lesions
100. The Role Of Interleukin-35 In The Pathogenesis Of Systemic Sclerosis
  <<First  <Prev  Next>  Last>>  Jump to